Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2005
12/29/2005US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/29/2005US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005US20050288265 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copd
12/29/2005US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
12/29/2005US20050288261 Compositions and method for treating infection in cattle and swine
12/29/2005US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine.
12/29/2005US20050288237 Novel derivative of flavone c-glycoside and composition containing the same
12/29/2005US20050288219 Osteoprotegerin in milk
12/29/2005US20050288211 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005US20050287546 Novel proteases
12/29/2005US20050287159 Treatment methods for eotaxin mediated inflammatory conditons
12/29/2005US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis
12/29/2005US20050287079 Combinations of formoterol and fluticasone propionate for asthma
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2570170A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609471A1 Remedy and/or preventive for lung diseases
12/28/2005EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
12/28/2005EP1608647A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors
12/28/2005EP1608388A1 Method for the production of an extract of ivy leaves
12/28/2005EP1608365A1 Method for treating vascular hyperpermeable disease
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608310A2 Methods and compositions for blocking the calcium cascade
12/28/2005EP1529040B1 Endiandric acid h derivatives as c-maf inhibitors for using against asthma
12/28/2005EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament
12/28/2005EP1377593B1 2-amino-propanol derivatives
12/28/2005EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them
12/28/2005EP1223170B1 Pyrimidine-5-carboxamide compounds, process for producing the same and use thereof
12/28/2005EP1135158B1 Enhanced vaccines based on chimeric immunoglobulin e peptides
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP0920315B1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714093A Diazinopyrimidines
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713914A Novel medicaments for the treatment of chronic obstructive pulmonary diseases
12/28/2005CN1713903A New synergistic combination comprising roflumilast and formoterol
12/28/2005CN1713902A Synergistic combination comprising roflumilas and (R,R) -formoterol
12/28/2005CN1233643C Ramification of a compound of medication as well as preparation method and application
12/28/2005CN1233408C Tablet medicine for treating pharyngolaryngitis and its preparation method
12/28/2005CN1233402C Syrup for treating cough and preparation method
12/28/2005CN1233400C Fever bringing down formulation for preventing virus and its prepn. method
12/28/2005CN1233399C Effervescence tablet of radix isatidis and its preparation
12/28/2005CN1233397C Shuanghuanglian effervescence tablet and its preparation
12/28/2005CN1233378C Chinese medicine composition for treating oral cavity and throat diseases and its preparing method
12/28/2005CN1233366C Chinese medicinal preparations for preventing and treating chronic bronchitis and obstructive emphysema
12/28/2005CN1233358C Method for extracting substance resisting respiratory syncytial virus from patrinia
12/28/2005CN1233349C Heat-clearing, toxin-expelling, swell-subsiding Chinese medicinal composition and its use
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979689 Antitussive, decongestant and diphenhydramine antihistamine; cough, congestion and allergy symptom relief
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979463 Stable extended release oral dosage composition
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005120574A1 Drug having regulatory cell ligand contained in liposome
12/22/2005WO2005120556A1 Human lysozyme medicine, its manufacturing method and application thereof
12/22/2005WO2005120485A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005WO2005120484A1 Regulator for physiological functions of ghrelin
12/22/2005WO2005120148A2 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282786 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
12/22/2005US20050282762 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005DE102004024451A1 Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten Powder formulations for inhalation which contain Enantiomerically pure beta agonists
12/22/2005CA2569743A1 Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
12/22/2005CA2569678A1 Regulator of physiological function of ghrelin and use thereof
12/22/2005CA2569590A1 Drug having regulatory cell ligand contained in liposome
12/22/2005CA2567821A1 Quinazolinone derivatives useful as vanilloid antagonists
12/21/2005EP1606630A2 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4)
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711093A Process to minimize loss through adhesion to equipment surfaces
12/21/2005CN1711082A Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232520C Salts of bicyclic N-acylated imidazo-3-amines and imidazo-5-amines
12/21/2005CN1232295C White flagger oral liquid and its preparing method
1 ... 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 ... 878